We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIO
2376
DELISTED
City Office REIT
CIO
$162K ﹤0.01%
19,371
-4,246
-18% -$40.8K
CCCC icon
2377
C4 Therapeutics
CCCC
$498M
$162K ﹤0.01%
27,475
IPI icon
2378
Intrepid Potash
IPI
$483M
$162K ﹤0.01%
5,611
OFLX icon
2379
Omega Flex
OFLX
$278M
$161K ﹤0.01%
1,726
+120
+7% +$11.4K
ERAS icon
2380
Erasca
ERAS
$6.31B
$161K ﹤0.01%
37,277
GH icon
2381
Guardant Health
GH
$21.6B
$160K ﹤0.01%
5,891
-155
-3% -$7.09K
ESQ icon
2382
Esquire Financial Holdings
ESQ
$1.6B
$160K ﹤0.01%
3,699
EGRX
2383
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$160K ﹤0.01%
5,468
RARE icon
2384
Ultragenyx Pharmaceutical
RARE
$2.62B
$160K ﹤0.01%
3,448
-82
-2% -$3.23K
DJCO icon
2385
Daily Journal
DJCO
$790M
$159K ﹤0.01%
635
+71
+13% +$19.2K
PAHC icon
2386
Phibro Animal Health
PAHC
$1.38B
$159K ﹤0.01%
11,856
GEVO icon
2387
Gevo
GEVO
$401M
$159K ﹤0.01%
83,471
-19,902
-19% -$42K
AMPS
2388
DELISTED
Altus Power
AMPS
$159K ﹤0.01%
24,321
FUTU icon
2389
Futu Holdings
FUTU
$14.6B
$159K ﹤0.01%
3,900
ROKU icon
2390
Roku
ROKU
$22.7B
$158K ﹤0.01%
3,887
+19
+0.5% +$993
GNTY
2391
DELISTED
Guaranty Bancshares
GNTY
$158K ﹤0.01%
4,563
ICPT
2392
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$158K ﹤0.01%
12,747
INDT
2393
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$158K ﹤0.01%
2,482
WRLD icon
2394
World Acceptance Corp
WRLD
$888M
$157K ﹤0.01%
2,385
COLD icon
2395
Americold
COLD
$4.35B
$157K ﹤0.01%
5,555
+27
+0.5% +$727
EVER icon
2396
EverQuote
EVER
$868M
$157K ﹤0.01%
+10,626
New +$99.8K
DMRC icon
2397
Digimarc Corp
DMRC
$161M
$157K ﹤0.01%
8,465
TARS icon
2398
Tarsus Pharmaceuticals
TARS
$3.02B
$156K ﹤0.01%
10,674
FBIZ icon
2399
First Business Financial Services
FBIZ
$600M
$156K ﹤0.01%
4,273
MCBC
2400
DELISTED
Macatawa Bank Corp
MCBC
$155K ﹤0.01%
14,024

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.